RecruitingNCT06611293

HOspital Versus Primary Care Breath Test Environment (HOPE) Study


Sponsor

Imperial College London

Enrollment

80 participants

Start Date

Feb 5, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

Through the HOPE study, the intention would be to determine whether exhaled breath volatile organic compound (VOC) profiles in Primary care differ from Secondary care. The intention would also be to assess intra-subject variability of participants. This would allow us to determine if the results of breath samples are reproducible regardless of whether they are performed in a Primary or Secondary care environment. This would support the clinical translation of breath research outcomes from studies performed in Secondary care, despite the breath test being intended for use in Primary care. The chief investigator of the HOPE study is Professor George Hanna (Head of Department of Surgery and Cancer, and Professor of Surgical Sciences at Imperial College London).


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Participants will be:
  • Aged ≥ 18 years old
  • Willing and able to provide informed consent to take part in study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBreath test

Participants will perform breath testing in Primary care followed by Secondary care on Day 1. At each location, participants will be asked to perform three breath tests (15 minutes apart). The environmental air will also be sampled. This entire process will be repeated in the reverse order (i.e. breath testing in Secondary care followed by Primary care on Day 2). Participants will be asked to maintain a clear fluid diet for a minimum of six hours prior to breath collection on both Day 1 and Day 2 of sampling.


Locations(2)

Imperial College London

London, United Kingdom

Imperial College London

London, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06611293


Related Trials